TMA Pro

The platform originates from a research project focused on the development of innovative solutions for the early identification of Thrombotic Microangiopathy, or TMA, in hospital settings.

Its development followed a two-stage evolution pathway. The first phase focused on the study of a dedicated algorithm, while the second phase led to the creation of a technological platform capable of using the algorithm as a predictive engine and integrating it with hospital information systems.

Starting from the retrospective analysis of clinical and laboratory data, which was useful for identifying the main indicators associated with the disease, the development pathway then focused on specialising the predictive algorithm.

The objective was to make the algorithm capable of supporting users in the timely recognition of clinically significant cases, laying the foundations for integration into clinical and care processes.

Following the completion of the platform development, the current evolution pathway is focused on performance optimisation through the introduction of new AI-based components.